Small cell lung cancer (SCLC) is usually staged as either limited or extensive. For treatment of limited-stage SCLC, a combination of chemotherapy and radiation is usually given. For treatment of extensive-stage SCLC, a combination of chemotherapy and immunotherapy is usually given.

For treatment purposes, most doctors use a 2-stage system that divides SCLC into limited stage and extensive stage. For limited-stage cancer, a person might benefit from more aggressive treatments such as chemotherapy combined with radiation therapy to try to cure the cancer.

SCLC is a very chemosensitive tumor with a response rate of 70–90%, and the basis of treatment for most patients in the limited stage of the disease is chemoradiotherapy. The preferred chemotherapy regimen is cisplatin 75 mg/m 2 day one and etoposide 100 to 120 mg/m 2 day 1–3 combined with external radiotherapy in a total dose of 45 Gy ...

Staging for small cell lung cancer (SCLC) can help identify how advanced the cancer is and its best treatment. In addition to the “limited” or “extensive” stages, doctors also classify SCLC...

Durvalumab (Imfinzi®) 6: Approved as a single agent, for the treatment of adult patients with limited-stage small cell lung cancer (LS-SCLC) whose disease has not progressed following concurrent platinum-based chemotherapy and radiation therapy; Extensive-stage disease. Combination chemotherapy